These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 16136489

  • 1. Anagrelide does not exert a myelodysplastic effect on megakaryopoiesis: a comparative immunohistochemical and morphometric study with hydroxyurea.
    Thiele J, Kvasnicka HM, Ollig S, Schmitt-Gräff A.
    Histol Histopathol; 2005 Oct; 20(4):1071-6. PubMed ID: 16136489
    [Abstract] [Full Text] [Related]

  • 2. Effects of anagrelide on megakaryopoiesis and platelet production.
    Thiele J, Kvasnicka HM, Schmitt-Graeff A.
    Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):352-61. PubMed ID: 16810611
    [Abstract] [Full Text] [Related]

  • 3. Anagrelide-induced bone marrow changes during therapy of chronic myeloproliferative disorders with thrombocytosis. an immunohistochemical and morphometric study of sequential trephine biopsies.
    Thiele J, Kvasnicka HM, Fuchs N, Brunnbauer K, Volkwein N, Schmitt-Graeff A.
    Haematologica; 2003 Oct; 88(10):1130-8. PubMed ID: 14555309
    [Abstract] [Full Text] [Related]

  • 4. [Anagrelide-induced changes of megakaryopoiesis during therapy of chronic myeloproliferative disorders with thrombocythemia].
    Thiele J, Kvasnicka HM, Schmitt-Gräff A.
    Pathologe; 2002 Nov; 23(6):426-32. PubMed ID: 12436295
    [Abstract] [Full Text] [Related]

  • 5. Effects of interferon and hydroxyurea on bone marrow fibrosis in chronic myelogenous leukaemia: a comparative retrospective multicentre histological and clinical study.
    Thiele J, Kvasnicka HM, Schmitt-Graeff A, Spohr M, Diehl V, Zankovich R, Niederle N, Leder LD.
    Br J Haematol; 2000 Jan; 108(1):64-71. PubMed ID: 10651725
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Histologic and hematological findings in CML. A comparative immunohistochemical-morphometric and clinical study on bone marrow biopsies from 604 patients derived from two institutes of pathology (Cologne/Freiburg)].
    Thiele J, Kvasnicka HM, Schmitt-Graeff A, Schaefer HE.
    Pathologe; 2000 Jan; 21(1):39-54. PubMed ID: 10663668
    [Abstract] [Full Text] [Related]

  • 11. Therapy-related changes of the bone marrow in chronic idiopathic myelofibrosis.
    Thiele J, Kvasnicka HM, Schmitt-Gräff A, Hülsemann R, Diehl V.
    Histol Histopathol; 2004 Jan; 19(1):239-50. PubMed ID: 14702192
    [Abstract] [Full Text] [Related]

  • 12. Megakaryocytopoiesis in bone marrow biopsies of patients with acquired immunodeficiency syndrome (AIDS). An immunohistochemical and morphometric evaluation with special emphasis on myelodysplastic features and precursor cells.
    Thiele J, Titius BR, Quitmann H, Fischer R, Salzberger B, Dienemann D, Stein H.
    Pathol Res Pract; 1992 Aug; 188(6):722-8. PubMed ID: 1437834
    [Abstract] [Full Text] [Related]

  • 13. Comparison between anagrelide and hydroxycarbamide in their activities against haematopoietic progenitor cell growth and differentiation: selectivity of anagrelide for the megakaryocytic lineage.
    Hong Y, Wang G, Del Arroyo AG, Hernandez J, Skene C, Erusalimsky JD.
    Leukemia; 2006 Jun; 20(6):1117-22. PubMed ID: 16557242
    [Abstract] [Full Text] [Related]

  • 14. Myelodysplastic syndromes: immunohistochemical and morphometric evaluation of proliferative activity in erythropoiesis and endoreduplicative capacity of megakaryocytes.
    Thiele J, Hoffmann I, Bertsch HP, Fischer R.
    Virchows Arch A Pathol Anat Histopathol; 1993 Jun; 423(1):33-8. PubMed ID: 8105604
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The gene expression signature of anagrelide provides an insight into its mechanism of action and uncovers new regulators of megakaryopoiesis.
    Ahluwalia M, Butcher L, Donovan H, Killick-Cole C, Jones PM, Erusalimsky JD.
    J Thromb Haemost; 2015 Jun; 13(6):1103-12. PubMed ID: 25851510
    [Abstract] [Full Text] [Related]

  • 17. Interferon therapy, but not busulfan restores normal-sized megakaryopoiesis in CML--a comparative histo- and immunomorphometric study.
    Thiele J, Zirbes T, Kvasnicka HM, Niederle N, Dammasch J, Schmidt M, Windecker R, Leder LD, Diehl V, Fischer R.
    Anal Cell Pathol; 1996 Jun; 11(1):31-42. PubMed ID: 8844103
    [Abstract] [Full Text] [Related]

  • 18. Effects of chemotherapy (busulfan-hydroxyurea) and interferon-alfa on bone marrow morphologic features in chronic myelogenous leukemia. Histochemical and morphometric study on sequential trephine biopsy specimens with special emphasis on dynamic features.
    Thiele J, Kvasnicka HM, Schmitt-Graeff A, Bundschuh S, Biermann T, Roessler G, Wasmus M, Diehl V, Zankovich R, Schaefer HE.
    Am J Clin Pathol; 2000 Jul; 114(1):57-65. PubMed ID: 10884800
    [Abstract] [Full Text] [Related]

  • 19. [Immunohistochemistry and morphometry of bone marrow in acquired immunodeficiency syndrome with special emphasis on megakaryopoiesis and macrophages].
    Thiele J, Titius B, Dienemann D, Falini B, Wagner S, Stein H, Fischer R.
    Verh Dtsch Ges Pathol; 1991 Jul; 75():126-30. PubMed ID: 1724814
    [Abstract] [Full Text] [Related]

  • 20. [Importance of immunomorphometric evaluation of the size and number of megakaryocytes in normal and pathologic bone marrow].
    Marisavljević D, Rolović Z, Mitrović D.
    Srp Arh Celok Lek; 1993 Jul; 121(3-7):57-61. PubMed ID: 7716637
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.